Cargando…

Shifting the balance of mitochondrial apoptosis: therapeutic perspectives

Signaling via the intrinsic (mitochondrial) pathway of apoptosis represents one of the critical signal transduction cascades that control the regulation of cell death. This pathway is typically altered in human cancers, thereby providing a suitable target for therapeutic intervention. Members of the...

Descripción completa

Detalles Bibliográficos
Autor principal: Fulda, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465793/
https://www.ncbi.nlm.nih.gov/pubmed/23061040
http://dx.doi.org/10.3389/fonc.2012.00121
_version_ 1782245583690399744
author Fulda, Simone
author_facet Fulda, Simone
author_sort Fulda, Simone
collection PubMed
description Signaling via the intrinsic (mitochondrial) pathway of apoptosis represents one of the critical signal transduction cascades that control the regulation of cell death. This pathway is typically altered in human cancers, thereby providing a suitable target for therapeutic intervention. Members of the Bcl-2 family of proteins as well as cell survival signaling cascades such as the PI3K/Akt/mTOR pathway are involved in the regulation of mitochondria-mediated apoptosis. Therefore, further insights into the molecular mechanisms that form the basis for the control of mitochondria-mediated apoptosis will likely open new perspectives to bypass evasion of apoptosis and treatment resistance in human cancers.
format Online
Article
Text
id pubmed-3465793
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-34657932012-10-11 Shifting the balance of mitochondrial apoptosis: therapeutic perspectives Fulda, Simone Front Oncol Oncology Signaling via the intrinsic (mitochondrial) pathway of apoptosis represents one of the critical signal transduction cascades that control the regulation of cell death. This pathway is typically altered in human cancers, thereby providing a suitable target for therapeutic intervention. Members of the Bcl-2 family of proteins as well as cell survival signaling cascades such as the PI3K/Akt/mTOR pathway are involved in the regulation of mitochondria-mediated apoptosis. Therefore, further insights into the molecular mechanisms that form the basis for the control of mitochondria-mediated apoptosis will likely open new perspectives to bypass evasion of apoptosis and treatment resistance in human cancers. Frontiers Media S.A. 2012-10-08 /pmc/articles/PMC3465793/ /pubmed/23061040 http://dx.doi.org/10.3389/fonc.2012.00121 Text en Copyright © 2012 Fulda. http://www.frontiersin.org/licenseagreement This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Oncology
Fulda, Simone
Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
title Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
title_full Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
title_fullStr Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
title_full_unstemmed Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
title_short Shifting the balance of mitochondrial apoptosis: therapeutic perspectives
title_sort shifting the balance of mitochondrial apoptosis: therapeutic perspectives
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3465793/
https://www.ncbi.nlm.nih.gov/pubmed/23061040
http://dx.doi.org/10.3389/fonc.2012.00121
work_keys_str_mv AT fuldasimone shiftingthebalanceofmitochondrialapoptosistherapeuticperspectives